iLife Discoveries, the Genetics and genomics firm is looking at bringing benefits of genetic tests for providing appropriate diagnostics and treatment options for various diseases in India.
The core areas of the company include oncology, mother and child initiative and neuro-psychiatry. "We have set up a core laboratory facility in India to translate genetics and genomics information from labs to bed-sides in hospitals," said iLife Discoveries Founder and CMD Anand Gupta.
The firm currently has a total of around 50 tests such as psychogenetic tests, new born screening tests and MammaPrint and Blueprint tests for breast cancer, among others, for early diagnostics and treatment.
"For neuro-psychiatry area, we have collaborated with a company called AB-Biotics for bringing a test called neuropharmagen in India for people suffering from depression which is a huge problem in the country," said Gupta.
Oncology is another area, which the company wants to focus on and for this, "Among others, we have also partnered with the US-based firm Agendia for their tests, MammaPrint and BluePrint."
The company is also in the process of entering into more exclusive tie-ups with various other companies and is also looking for expanding its workforce for future growth, said Gupta.